Re: Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter-Reference-Cited by-同舟云学术

Re: Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter

Published:2022-04-29 Issue:7 Volume:40 Page:1893-1894
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Deng Changkai^ORCID,Dai Rong

Funder

Health Commission of Sichuan Province

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

https://link.springer.com/content/pdf/10.1007/s00345-022-04020-4.pdf

Reference5 articles.

1. de Sallmard G, Perrouin-Verbe MA, Peyronnet B et al (2022) Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter. World J Urol 40:489–495. https://doi.org/10.1007/s00345-021-03850-y

2. Deng C, Chen Y, Dai R (2022) Re: Safety and short-term efficacy of mirabegron in children with valve bladder: a pilot study. Pediatr Surg Int. https://doi.org/10.1007/s00383-022-05120-3

3. Irwin DE, Mungapen L, Milsom I et al (2009) The economic impact of overactive bladder syndrome in six Western countries. BJU Int 103:202–209. https://doi.org/10.1111/j.1464-410X.2008.08036.x

4. O’Connor E, Nic An Riogh A, Karavitakis M et al (2021) Diagnosis and non-surgical management of urinary incontinence - a literature review with recommendations for practice. Int J Gen Med 14:4555–4565. https://doi.org/10.2147/IJGM.S289314

5. Lightner DJ, Gomelsky A, Souter L et al (2019) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline Amendment 2019. J Urol 202:558–563. https://doi.org/10.1097/JU.0000000000000309